Donate

remission

Home»Posts tagged with»remission

Qu Biologics Enrolls First Patient in Phase 1/2 Clinical Trial

Qu Biologics Enrolls First Patient in Phase 1/2 Clinical Trial

Qu Biologics Enrolls First Patient in Phase 1/2 Clinical Trial of QBECO SSI for the Treatment of Crohn’s Disease Vancouver, British Columbia – June 11, 2013 – Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to “reboot” the body’s immune system, announced it has enrolled its first patient in a […]

Janssen Biotech FDA approval Simponi Ulcerative Colitis

Janssen Biotech FDA approval Simponi Ulcerative Colitis Janssen Biotech has announced the FDA approval of Simponi (golimumab) to treat moderately to severely active ulcerative colitis (UC) in adult patients with corticosteroid dependence or an inadequate response to or failed to tolerate oral aminosalicylates, oral corticosteroids, azathioprine, or 6-mercaptopurine. The first and only subcutaneously administered anti-tumor […]

Ulcerative Colitis benefits from Fecal Transplants

Children with ulcerative colitis benefited from fecal transplants Family Practice News Digital Network Seven out of nine children with active ulcerative colitis experienced at least a temporary clinical response within 1 week of a series of fecal transplants – with four of the patients staying in complete remission 1 month later. The procedures … Tags: […]

Ulcerative Colitis First Patient in Phase 2 Trial RPC1063

Receptos Doses First Patient in Phase 2 Trial for RPC1063 in Ulcerative ColitisPR Newswire (press release)"RPC1063 not only has the potential to demonstrate efficacy in both induction and maintenance therapy for ulcerative colitis, but could repre…

NEOVACS Final Results of the Phase II Study in Crohns

NEOVACS : Final Results of the Phase II Study in Crohn's4-tradersNEOVACS (Paris:ALNEV) (Alternext Paris : ALNEV), a leader in active immunotherapies for the treatment of autoimmune diseases today announced the final results of the Phase II study of…

Teva Reports Laquinimod Phase IIa trial positive results

Teva reports Laquinimod Phase IIa trial positive resultsPharmaceutical Business ReviewTeva Pharmaceutical Industries and Active Biotech have presented positive data from Phase IIa trial designed to evaluate the safety and efficacy of laquinimod in pati…

New Guidelines on Crohn’s Disease Released

New guidelines on Crohn's disease released by NICELabmate OnlineGuidance on the role of new and established treatments for the management of Crohn's disease in adults and children has been published by The National Institute for Health and Clin…

Phase 3 Study Results Show Anti-TNF SIMPONI® Active Ulcerative Colitis

Phase 3 Study Results Show Anti-TNF SIMPONI® Active Ulcerative Colitis

Phase 3 Study Results Show Anti-TNF SIMPONI® Induced Clinical Response in Adults With Moderately to Severely Active Ulcerative Colitis   First Presentation of Phase 3 Data Shows Significant Improvements in Clinical Remission, Mucosal Healing and Quality of Life Measures after SIMPONI Induction Treatment New study findings show that subcutaneous induction regimens of the anti-tumor necrosis […]

No Guts Know Glory

IDEAS Kids

IDEAS Kids

IBD Adventures